These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 10593300

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. The CYP2D6B allele is associated with a milder synaptic pathology in Alzheimer's disease.
    Chen X, Xia Y, Alford M, DeTeresa R, Hansen L, Klauber MR, Katzman R, Thal L, Masliah E, Saitoh T.
    Ann Neurol; 1995 Oct; 38(4):653-8. PubMed ID: 7574463
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies.
    Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Borr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG.
    J Neuropathol Exp Neurol; 2013 Jan; 72(1):53-60. PubMed ID: 23242284
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Loss of serotonin 5-HT2A receptors in the postmortem temporal cortex correlates with rate of cognitive decline in Alzheimer's disease.
    Lai MK, Tsang SW, Alder JT, Keene J, Hope T, Esiri MM, Francis PT, Chen CP.
    Psychopharmacology (Berl); 2005 May; 179(3):673-7. PubMed ID: 15551121
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Trajectories of cognitive decline in different types of dementia.
    Smits LL, van Harten AC, Pijnenburg YA, Koedam EL, Bouwman FH, Sistermans N, Reuling IE, Prins ND, Lemstra AW, Scheltens P, van der Flier WM.
    Psychol Med; 2015 Apr; 45(5):1051-9. PubMed ID: 25229325
    [Abstract] [Full Text] [Related]

  • 49. Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients.
    Pappas BA, Bayley PJ, Bui BK, Hansen LA, Thal LJ.
    Neurobiol Aging; 2000 Apr; 21(1):11-7. PubMed ID: 10794843
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.
    Hansen L, Salmon D, Galasko D, Masliah E, Katzman R, DeTeresa R, Thal L, Pay MM, Hofstetter R, Klauber M.
    Neurology; 1990 Jan; 40(1):1-8. PubMed ID: 2153271
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Cholinergic deficits contribute to behavioral disturbance in patients with dementia.
    Minger SL, Esiri MM, McDonald B, Keene J, Carter J, Hope T, Francis PT.
    Neurology; 2000 Nov 28; 55(10):1460-7. PubMed ID: 11094098
    [Abstract] [Full Text] [Related]

  • 55. Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease.
    Dournaud P, Delaere P, Hauw JJ, Epelbaum J.
    Neurobiol Aging; 1995 Nov 28; 16(5):817-23. PubMed ID: 8532116
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease.
    Wakabayashi K, Honer WG, Masliah E.
    Brain Res; 1994 Dec 19; 667(1):24-32. PubMed ID: 7895080
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.